Literature DB >> 7772513

A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia.

S Hayette1, L Morle, M Bozon, A Ghanem, M Risinger, C Korsgren, M J Tanner, S Fattoum, C M Cohen, J Delaunay.   

Abstract

A recessively transmitted haemolytic anaemia associated with the lack of protein 4.2 was found in a Tunisian kindred. Trace amounts of this protein (72 kD component) became visible using high-sensitivity Western blots. Band 3 and ankyrin genes were excluded as candidate genes by linkage studies, and nucleotide sequencing of band 3 cytoplasmic domain cDNA revealed no alteration. In contrast, protein 4.2 gene contained in the homozygous state a mutation at position 310: CGA-->CAA (Arg-->Gln). This mutation defining allele 4.2 Tozeur was co-inherited with the disease. The mRNA encoding the variant protein was normal in size and approximately normal in amount. Recombinant protein 4.2 Tozeur bound normally to red cell IOVs but disclosed an increased susceptibility to proteolysis in vitro. We infer that the nearly total absence of protein 4.2 in the patients results from imbalance between destruction and synthesis of mutated protein 4.2 prior to its binding to the membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772513     DOI: 10.1111/j.1365-2141.1995.tb08413.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2.

Authors:  Debabrata Mandal; Prasun K Moitra; Joyoti Basu
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Compound heterozygosity for two novel mutations in the erythrocyte protein 4.2 gene causing spherocytosis in a Caucasian patient.

Authors:  Adrienne M Hammill; Mary A Risinger; Clinton H Joiner; Mehdi Keddache; Theodosia A Kalfa
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

3.  Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (-) cells (mutations Chartres 1 and 2).

Authors:  Emile van den Akker; Timothy J Satchwell; Stephanie Pellegrin; Joanna F Flatt; Michel Maigre; Geoff Daniels; Jean Delaunay; Lesley J Bruce; Ashley M Toye
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

4.  Associations of protein 4.2 with band 3 and ankyrin.

Authors:  Yang Su; Yu Ding; Ming Jiang; Weihua Jiang; Xiaojian Hu; Zhihong Zhang
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

5.  Control of band 3 lateral and rotational mobility by band 4.2 in intact erythrocytes: release of band 3 oligomers from low-affinity binding sites.

Authors:  D E Golan; J D Corbett; C Korsgren; H S Thatte; S Hayette; Y Yawata; C M Cohen
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

6.  Ankyrin gene mutations in japanese patients with hereditary spherocytosis.

Authors:  H Nakanishi; A Kanzaki; A Yawata; O Yamada; Y Yawata
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

7.  Combination of two mutant alpha spectrin alleles underlies a severe spherocytic hemolytic anemia.

Authors:  H Wichterle; M Hanspal; J Palek; P Jarolim
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

8.  The use of real-time PCR technique in the detection of novel protein 4.2 gene mutations that coexist with thalassaemia alpha in a single patient.

Authors:  Monika Maciag; Anna Adamowicz-Salach; Alicja Siwicka; Justyna Spychalska; Beata Burzynska
Journal:  Eur J Haematol       Date:  2009-06-08       Impact factor: 2.997

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.